Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Almut Nebel is active.

Publication


Featured researches published by Almut Nebel.


Proceedings of the National Academy of Sciences of the United States of America | 2009

Association of FOXO3A variation with human longevity confirmed in German centenarians

Friederike Flachsbart; Amke Caliebe; Rabea Kleindorp; Hélène Blanché; Huberta von Eller-Eberstein; Susanna Nikolaus; Stefan Schreiber; Almut Nebel

The human forkhead box O3A gene (FOXO3A) encodes an evolutionarily conserved key regulator of the insulin–IGF1 signaling pathway that is known to influence metabolism and lifespan in model organisms. A recent study described 3 SNPs in the FOXO3A gene that were statistically significantly associated with longevity in a discovery sample of long-lived men of Japanese ancestry [Willcox et al. (2008) Proc Natl Acad Sci USA 105:13987–13992]. However, this finding required replication in an independent population. Here, we have investigated 16 known FOXO3A SNPs in an extensive collection of 1,762 German centenarians/nonagenarians and younger controls and provide evidence that polymorphisms in this gene were indeed associated with the ability to attain exceptional old age. The FOXO3A association was considerably stronger in centenarians than in nonagenarians, highlighting the importance of centenarians for genetic longevity research. Our study extended the initial finding observed in Japanese men to women and indicates that both genders were likely to be equally affected by variation in FOXO3A. Replication in a French centenarian sample generated a trend that supported the previous results. Our findings confirmed the initial discovery in the Japanese sample and indicate FOXO3A as a susceptibility gene for prolonged survival in humans.


Science | 2013

Genome-wide comparison of medieval and modern Mycobacterium leprae

Verena J. Schuenemann; Pushpendra Singh; Thomas A. Mendum; Ben Krause-Kyora; Günter Jäger; Kirsten I. Bos; Alexander Herbig; Christos Economou; Andrej Benjak; Philippe Busso; Almut Nebel; Jesper Lier Boldsen; Anna Kjellström; Huihai Wu; Graham R. Stewart; G. Michael Taylor; Peter Bauer; Oona Y.-C. Lee; Houdini H.T. Wu; David E. Minnikin; Gurdyal S. Besra; Katie Tucker; Simon Roffey; Samba O. Sow; Stewart T. Cole; Kay Nieselt; Johannes Krause

Leprosy: Ancient and Modern In medieval Europe, leprosy was greatly feared: Sufferers had to wear bells and were shunned and kept isolated from society. Although leprosy largely disappeared from Europe in the 16th century, elsewhere in the world almost a quarter of a million cases are still reported annually, despite the availability of effective drugs. Schuenemann et al. (p. 179, published online 13 June; see the 14 June News story by Gibbons, p. 1278) probed the origins of leprosy bacilli by using a genomic capture-based approach on DNA obtained from skeletal remains from the 10th to 14th centuries. Because the unique mycolic acids of this mycobacterium protect its DNA, for one Danish sample over 100-fold, coverage of the genome was possible. Sequencing suggests a link between the middle-eastern and medieval European strains, which falls in line with social historical expectations that the returning expeditionary forces of antiquity originally spread the pathogen. Subsequently, Europeans took the bacterium westward to the Americas. Overall, ancient and modern strains remain remarkably similar, with no apparent loss of virulence genes, indicating it was most probably improvements in social conditions that led to leprosys demise in Europe. Five European individuals who lived during the Middle Ages provide a look backward at leprosy. Leprosy was endemic in Europe until the Middle Ages. Using DNA array capture, we have obtained genome sequences of Mycobacterium leprae from skeletons of five medieval leprosy cases from the United Kingdom, Sweden, and Denmark. In one case, the DNA was so well preserved that full de novo assembly of the ancient bacterial genome could be achieved through shotgun sequencing alone. The ancient M. leprae sequences were compared with those of 11 modern strains, representing diverse genotypes and geographic origins. The comparisons revealed remarkable genomic conservation during the past 1000 years, a European origin for leprosy in the Americas, and the presence of an M. leprae genotype in medieval Europe now commonly associated with the Middle East. The exceptional preservation of M. leprae biomarkers, both DNA and mycolic acids, in ancient skeletons has major implications for palaeomicrobiology and human pathogen evolution.


Mechanisms of Ageing and Development | 2011

A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals

Almut Nebel; Rabea Kleindorp; Amke Caliebe; Michael Nothnagel; Hélène Blanché; Olaf Junge; Michael Wittig; David Ellinghaus; Friederike Flachsbart; Heinz-Erich Wichmann; Thomas Meitinger; Susanna Nikolaus; Andre Franke; Michael Krawczak; Mark Lathrop; Stefan Schreiber

We conducted a case-control genome-wide association study (GWAS) of human longevity, comparing 664,472 autosomal SNPs in 763 long-lived individuals (LLI; mean age: 99.7 years) and 1085 controls (mean age: 60.2 years) from Germany. Only one association, namely that of SNP rs4420638 near the APOC1 gene, achieved genome-wide significance (allele-based P=1.8×10(-10)). However, logistic regression analysis revealed that this association, which was replicated in an independent German sample, is fully explicable by linkage disequilibrium with the APOE allele ɛ4, the only variant hitherto established as a major genetic determinant of survival into old age. Our GWAS failed to identify any additional autosomal susceptibility genes. One explanation for this lack of success in our study would be that GWAS provide only limited statistical power for a polygenic phenotype with loci of small effect such as human longevity. A recent GWAS in Dutch LLI independently confirmed the APOE-longevity association, thus strengthening the conclusion that this locus is a very, if not the most, important genetic factor influencing longevity.


American Journal of Human Genetics | 2001

The Y Chromosome Pool of Jews as Part of the Genetic Landscape of the Middle East

Almut Nebel; Dvora Filon; Partha P. Majumder; Marina Faerman; Ariella Oppenheim

A sample of 526 Y chromosomes representing six Middle Eastern populations (Ashkenazi, Sephardic, and Kurdish Jews from Israel; Muslim Kurds; Muslim Arabs from Israel and the Palestinian Authority Area; and Bedouin from the Negev) was analyzed for 13 binary polymorphisms and six microsatellite loci. The investigation of the genetic relationship among three Jewish communities revealed that Kurdish and Sephardic Jews were indistinguishable from one another, whereas both differed slightly, yet significantly, from Ashkenazi Jews. The differences among Ashkenazim may be a result of low-level gene flow from European populations and/or genetic drift during isolation. Admixture between Kurdish Jews and their former Muslim host population in Kurdistan appeared to be negligible. In comparison with data available from other relevant populations in the region, Jews were found to be more closely related to groups in the north of the Fertile Crescent (Kurds, Turks, and Armenians) than to their Arab neighbors. The two haplogroups Eu 9 and Eu 10 constitute a major part of the Y chromosome pool in the analyzed sample. Our data suggest that Eu 9 originated in the northern part, and Eu 10 in the southern part of the Fertile Crescent. Genetic dating yielded estimates of the expansion of both haplogroups that cover the Neolithic period in the region. Palestinian Arabs and Bedouin differed from the other Middle Eastern populations studied here, mainly in specific high-frequency Eu 10 haplotypes not found in the non-Arab groups. These chromosomes might have been introduced through migrations from the Arabian Peninsula during the last two millennia. The present study contributes to the elucidation of the complex demographic history that shaped the present-day genetic landscape in the region.


Human Molecular Genetics | 2014

Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age

Joris Deelen; Marian Beekman; Hae-Won Uh; Linda Broer; Kristin L. Ayers; Qihua Tan; Yoichiro Kamatani; Anna M. Bennet; Riin Tamm; Stella Trompet; Daníel F. Guðbjartsson; Friederike Flachsbart; Giuseppina Rose; Alexander Viktorin; Krista Fischer; Marianne Nygaard; Heather J. Cordell; Paolina Crocco; Erik B. van den Akker; Stefan Böhringer; Quinta Helmer; Christopher P. Nelson; Gary Saunders; Maris Alver; Karen Andersen-Ranberg; Marie E. Breen; Ruud van der Breggen; Amke Caliebe; Miriam Capri; Elisa Cevenini

The genetic contribution to the variation in human lifespan is ∼25%. Despite the large number of identified disease-susceptibility loci, it is not known which loci influence population mortality. We performed a genome-wide association meta-analysis of 7729 long-lived individuals of European descent (≥85 years) and 16 121 younger controls (<65 years) followed by replication in an additional set of 13 060 long-lived individuals and 61 156 controls. In addition, we performed a subset analysis in cases aged ≥90 years. We observed genome-wide significant association with longevity, as reflected by survival to ages beyond 90 years, at a novel locus, rs2149954, on chromosome 5q33.3 (OR = 1.10, P = 1.74 × 10−8). We also confirmed association of rs4420638 on chromosome 19q13.32 (OR = 0.72, P = 3.40 × 10−36), representing the TOMM40/APOE/APOC1 locus. In a prospective meta-analysis (n = 34 103), the minor allele of rs2149954 (T) on chromosome 5q33.3 associates with increased survival (HR = 0.95, P = 0.003). This allele has previously been reported to associate with low blood pressure in middle age. Interestingly, the minor allele (T) associates with decreased cardiovascular mortality risk, independent of blood pressure. We report on the first GWAS-identified longevity locus on chromosome 5q33.3 influencing survival in the general European population. The minor allele of this locus associates with low blood pressure in middle age, although the contribution of this allele to survival may be less dependent on blood pressure. Hence, the pleiotropic mechanisms by which this intragenic variation contributes to lifespan regulation have to be elucidated.


Aging Cell | 2013

Genome-wide linkage analysis for human longevity: Genetics of Healthy Aging Study

Marian Beekman; Hélène Blanché; Markus Perola; Anti Hervonen; Vladyslav Bezrukov; Ewa Sikora; Friederike Flachsbart; Lene Christiansen; Anton J. M. de Craen; Thomas B. L. Kirkwood; Irene Maeve Rea; Michel Poulain; Jean-Marie Robine; Silvana Valensin; Maria Antonietta Stazi; Giuseppe Passarino; Luca Deiana; Efstathios S. Gonos; Lavinia Paternoster; Thorkild Ingvor Arrild Sørensen; Qihua Tan; Quinta Helmer; Erik B. van den Akker; Joris Deelen; Francesca Martella; Heather J. Cordell; Kristin L. Ayers; James W. Vaupel; Outi Törnwall; Thomas E. Johnson

Clear evidence exists for heritability of human longevity, and much interest is focused on identifying genes associated with longer lives. To identify such longevity alleles, we performed the largest genome‐wide linkage scan thus far reported. Linkage analyses included 2118 nonagenarian Caucasian sibling pairs that have been enrolled in 15 study centers of 11 European countries as part of the Genetics of Healthy Aging (GEHA) project. In the joint linkage analyses, we observed four regions that show linkage with longevity; chromosome 14q11.2 (LOD = 3.47), chromosome 17q12‐q22 (LOD = 2.95), chromosome 19p13.3‐p13.11 (LOD = 3.76), and chromosome 19q13.11‐q13.32 (LOD = 3.57). To fine map these regions linked to longevity, we performed association analysis using GWAS data in a subgroup of 1228 unrelated nonagenarian and 1907 geographically matched controls. Using a fixed‐effect meta‐analysis approach, rs4420638 at the TOMM40/APOE/APOC1 gene locus showed significant association with longevity (P‐value = 9.6 × 10−8). By combined modeling of linkage and association, we showed that association of longevity with APOEε4 and APOEε2 alleles explain the linkage at 19q13.11‐q13.32 with P‐value = 0.02 and P‐value = 1.0 × 10−5, respectively. In the largest linkage scan thus far performed for human familial longevity, we confirm that the APOE locus is a longevity gene and that additional longevity loci may be identified at 14q11.2, 17q12‐q22, and 19p13.3‐p13.11. As the latter linkage results are not explained by common variants, we suggest that rare variants play an important role in human familial longevity.


Proceedings of the National Academy of Sciences of the United States of America | 2005

No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans

Almut Nebel; Peter J. P. Croucher; Rieke Stiegeler; Susanna Nikolaus; Michael Krawczak; Stefan Schreiber

Human longevity is a multifactorial condition with a significant genetic contribution. A recent association study in two independent samples of long-lived U.S. Caucasians [long-lived individuals (LLI)] identified a SNP haplotype of the microsomal triglyceride transfer protein (MTP, 4q25) that was underrepresented among LLI when compared with younger controls. This suggested that variation in the MTP gene might modify human longevity. Because of its function in lipid metabolism, the MTP gene product could plausibly play a pivotal role in the physiology of aging. However, the association observed in the U.S. samples could not be replicated by the same authors in a larger French LLI sample. We have therefore investigated the MTP “risk” haplotype in our own collection of 1,589 German nonagenarians, centenarians, and appropriately matched controls. No statistically significant differences were observed between LLI and controls at the allele, genotype, or haplotype level. This indicates that a noteworthy influence of the respective MTP haplotype on human longevity in the German population is unlikely. Furthermore, in comparison with all other U.S. and European samples analyzed, the MTP “risk” haplotype was found to be overrepresented only in the U.S. controls. This implies that the putative association is more likely to reflect recent changes in the genetic structure of the U.S. Caucasian population as a whole, rather than genetic effects upon survival to old age. In our view, the original study therefore highlights potential problems that arise when the case-control design is used as a means to map longevity genes in humans.


Leukemia | 2012

Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.

Eva Ellinghaus; Martin Stanulla; Gesa M. Richter; David Ellinghaus; G te Kronnie; Gunnar Cario; G Cazzaniga; M Horstmann; R Panzer Grümayer; Hélène Cavé; Jan Trka; O Cinek; Andrea Teigler-Schlegel; Abdou ElSharawy; Robert Häsler; Almut Nebel; B Meissner; Thies Bartram; Francesco Lescai; Claudio Franceschi; Marco Giordan; Peter Nürnberg; B Heinzow; Maya Zimmermann; Stefan Schreiber; Martin Schrappe; Andre Franke

Acute lymphoblastic leukemia (ALL) is a malignant disease of the white blood cells. The etiology of ALL is believed to be multifactorial and likely to involve an interplay of environmental and genetic variables. We performed a genome-wide association study of 355 750 single-nucleotide polymorphisms (SNPs) in 474 controls and 419 childhood ALL cases characterized by a t(12;21)(p13;q22) — the most common chromosomal translocation observed in childhood ALL — which leads to an ETV6–RUNX1 gene fusion. The eight most strongly associated SNPs were followed-up in 951 ETV6-RUNX1-positive cases and 3061 controls from Germany/Austria and Italy, respectively. We identified a novel, genome-wide significant risk locus at 3q28 (TP63, rs17505102, PCMH=8.94 × 10−9, OR=0.65). The separate analysis of the combined German/Austrian sample only, revealed additional genome-wide significant associations at 11q11 (OR8U8, rs1945213, P=9.14 × 10−11, OR=0.69) and 8p21.3 (near INTS10, rs920590, P=6.12 × 10−9, OR=1.36). These associations and another association at 11p11.2 (PTPRJ, rs3942852, P=4.95 × 10−7, OR=0.72) remained significant in the German/Austrian replication panel after correction for multiple testing. Our findings demonstrate that germline genetic variation can specifically contribute to the risk of ETV6–RUNX1-positive childhood ALL. The identification of TP63 and PTPRJ as susceptibility genes emphasize the role of the TP53 gene family and the importance of proteins regulating cellular processes in connection with tumorigenesis.


Aging Cell | 2012

Genome-wide miRNA signatures of human longevity

Abdou ElSharawy; Andreas Keller; Friederike Flachsbart; Anke Wendschlag; Gunnar Jacobs; Nathalie Kefer; Thomas Brefort; Petra Leidinger; Christina Backes; Eckart Meese; Stefan Schreiber; Philip Rosenstiel; Andre Franke; Almut Nebel

Little is known about the functions of miRNAs in human longevity. Here, we present the first genome‐wide miRNA study in long‐lived individuals (LLI) who are considered a model for healthy aging. Using a microarray with 863 miRNAs, we compared the expression profiles obtained from blood samples of 15 centenarians and nonagenarians (mean age 96.4 years) with those of 55 younger individuals (mean age 45.9 years). Eighty miRNAs showed aging‐associated expression changes, with 16 miRNAs being up‐regulated and 64 down‐regulated in the LLI relative to the younger probands. Seven of the eight selected aging‐related biomarkers were technically validated using quantitative RT‐PCR, confirming the microarray data. Three of the eight miRNAs were further investigated in independent samples of 15 LLI and 17 younger participants (mean age 101.5 and 36.9 years, respectively). Our screening confirmed previously published miRNAs of human aging, thus reflecting the utility of the applied approach. The hierarchical clustering analysis of the miRNA microarray expression data revealed a distinct separation between the LLI and the younger controls (P‐value < 10−5). The down‐regulated miRNAs appeared as a cluster and were more often reported in the context of diseases than the up‐regulated miRNAs. Moreover, many of the differentially regulated miRNAs are known to exhibit contrasting expression patterns in major age‐related diseases. Further in silico analyses showed enrichment of potential targets of the down‐regulated miRNAs in p53 and other cancer pathways. Altogether, synchronized miRNA–p53 activities could be involved in the prevention of tumorigenesis and the maintenance of genomic integrity during aging.


Neurology | 2012

Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor

Sandra Thier; Delia Lorenz; Michael Nothnagel; Caroline Poremba; Frank Papengut; Silke Appenzeller; Steffen Paschen; Frank Hofschulte; Anna-Christina Hussl; Sascha Hering; Werner Poewe; Friedrich Asmus; Thomas Gasser; Ludger Schöls; Kaare Christensen; Almut Nebel; Stefan Schreiber; Stephan Klebe; Günther Deuschl

Objective: Sporadic, genetically complex essential tremor (ET) is one of the most common movement disorders and may lead to severe impairment of the quality of life. Despite high heritability, the genetic determinants of ET are largely unknown. We performed the second genome-wide association study (GWAS) for ET to elucidate genetic risk factors of ET. Methods: Using the Affymetrix Genome-Wide SNP Array 6.0 (1000K) we conducted a two-stage GWAS in a total of 990 subjects and 1,537 control subjects from Europe to identify genetic variants associated with ET. Results: We discovered association of an intronic variant of the main glial glutamate transporter (SLC1A2) gene with ET in the first-stage sample (rs3794087, p = 6.95 × 10−5, odds ratio [OR] = 1.46). We verified the association of rs3794087 with ET in a second-stage sample (p = 1.25 × 10−3, OR = 1.38). In the subgroup analysis of patients classified as definite ET, rs3794087 obtained genome-wide significance (p = 3.44 × 10−10, OR = 1.59) in the combined first- and second-stage sample. Genetic fine mapping using nonsynonymous single nucleotide polymorphisms (SNPs) and SNPs in high linkage disequilibrium with rs3794087 did not reveal any SNP with a stronger association with ET than rs3794087. Conclusions: We identified SLC1A2 encoding the major glial high-affinity glutamate reuptake transporter in the brain as a potential ET susceptibility gene. Acute and chronic glutamatergic overexcitation is implied in the pathogenesis of ET. SLC1A2 is therefore a good functional candidate gene for ET.

Collaboration


Dive into the Almut Nebel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge